Singulair 10 mg, 5 mg, 4 mg FC Tablets, Chewable Tablets, SPRINKLES
PDF Leaflet Revision Date: 27 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
Adults: 10 mg daily; Children 6-14 years: 5 mg daily; Children 2-5 years: 4 mg daily or 1 packet of Sprinkles.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding.
Key Drug Interactions
- Phenobarbital
- Gemfibrozil
- Itraconazole
Contraindications
- Hypersensitivity to montelukast
- Children <2 years
- Children <6 years for certain formulations
Common side effects
- Headache
- Dizziness
- Fatigue
- Abdominal pain
Counselling Points
- Take daily as prescribed
- Continue during asthma worsening
- Report neuropsychiatric changes
Serious warnings
- Neuropsychiatric events
- Eosinophilia
- Not for acute asthma attacks
Important Disclaimer
The Singulair 10 mg, 5 mg, 4 mg FC Tablets, Chewable Tablets, SPRINKLES professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
